Sayona Mining Limited (ASX:SYA) Reports High-Grade Lithium Drill Results
Sayona Mining (ASX:SYA) announces substantial high-grade lithium drill results, enhancing the resource potential of its Moblan Lithium Project.
Tag: Investor Relations
Hansen Technologies Ltd (ASX:HSN) Acquires Strategic Assets in Germany
Hansen Technologies (ASX:HSN) acquires strategic software assets in Germany for A$13.4m, enhancing its market position and growth strategy.
Coventry Group Ltd (ASX:CYG) Announces Q3 FY25 Trading Update
Coventry Group Ltd (ASX:CYG) reports a 3.6% sales increase in Q3 FY25, despite a 41.1% drop in EBITDA, outlining strategic cost reductions for improved margins.
NOVONIX (ASX:NVX) Appoints Michael O’Kronley as CEO
NOVONIX (ASX:NVX) appoints Michael O’Kronley as CEO, marking a significant leadership change within the company.
Eagle Mountain Mining (ASX:EM2) Completes Rights Issue
Eagle Mountain Mining (ASX:EM2) completes rights issue, raising A$5.9 million and advancing key projects.
Surefire Resources NL (ASX:SRN) Announces Q1 2025 Highlights
Surefire Resources NL (ASX:SRN) extends Yidby gold mineralisation, advances copper systems, secures offtake agreement, and receives R&D rebate.
Future Battery Minerals (ASX:FBM) Identifies Key Gold Targets and Expands WA Landholdings
Future Battery Minerals (ASX:FBM) announces key gold targets at Kal North and expands Western Australia landholdings, enhancing exploration prospects.
Australian Rare Earths Limited (ASX:AR3) Completes EL6678 Farm-In
Australian Rare Earths Limited (ASX:AR3) finalises farm-in agreement for EL6678, expanding its Overland Uranium Project with promising exploration results.
PYC Therapeutics (ASX:PYC) Announces Q1 2025 Shareholder Update
PYC Therapeutics (ASX:PYC) extends cash runway to over $200m and advances polycystic kidney disease program in Q1 2025.
Cynata Therapeutics Limited (ASX:CYP) Releases Q1 2025 Activity Report
Cynata Therapeutics (ASX:CYP) reports progress in key clinical trials and maintains a strong financial position in Q1 2025.